| 1 |
32132025 | Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness. | 2020 Mar |
3 |
| 2 |
30448543 | Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype. | 2019 Mar 1 |
3 |
| 3 |
29022906 | Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals. | 2017 Oct 12 |
5 |
| 4 |
27688096 | The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals. | 2016 Oct |
5 |
| 5 |
24583399 | Involvement of androgen receptor and glucose-regulated protein 78 kDa in human hepatocarcinogenesis. | 2014 May 1 |
1 |
| 6 |
22383427 | Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways. | 2012 Jun |
4 |
| 7 |
23109869 | Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells. | 2012 |
4 |